Company Filing History:
1 out of 110 
1 out of 138 Years Active: 2002-2004
Title: The Innovations of Daniel Stinchcomb
Introduction
Daniel Stinchcomb is an accomplished inventor based in Boulder, CO. He has made significant contributions to the field of biotechnology, particularly in the treatment of diseases related to vascular endothelial growth factor receptors. With a total of 2 patents, his work has the potential to impact medical treatments significantly.
Latest Patents
Stinchcomb's latest patents include a method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor. This invention relates to nucleic acid molecules that modulate the synthesis, expression, and/or stability of an mRNA encoding one or more receptors of vascular endothelial growth factor. His innovative approach aims to provide new therapeutic options for patients suffering from related conditions.
Career Highlights
Throughout his career, Daniel Stinchcomb has worked with notable companies in the biotechnology sector. He has been associated with Ribozyme Pharmaceuticals, Incorporated and Sirna Therapeutics, Inc. These experiences have allowed him to develop and refine his inventions in a collaborative environment.
Collaborations
Some of his notable coworkers include Pamela Pavco and James A McSwiggen. Their collaboration has likely contributed to the advancement of his research and innovations.
Conclusion
Daniel Stinchcomb's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments.